Yes I also remember back then GKP, AOD9604 wasn't a complete failure, it was the delivery method that the management chose back then to change at the last minute, they went from an injectable to an oral formulation at the last hurdle of phase 3 , a bad move, and it wasn't a performance enhancing drug either, it was for muscle bone and cartilage repair, something I would have thought was of great use in football injuries, it was originally designed for helping get rid of tummy fat?
But the one thing good to come out of that investment was the fact that MBP had over $100 million in the bank, which was an ideal entry into the market by PNV and allowed MBP investors some very cheap shares back then, so all up an investment in MBP wasn't such a bad thing IMHO.
Enjoy your trip GKP and keep posting, as I like to hear something sensible here, something that is really lacking on this thread a lot of the time.
- Forums
- ASX - By Stock
- Trading update Q3 FY23
Yes I also remember back then GKP, AOD9604 wasn't a complete...
-
- There are more pages in this discussion • 136 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.61 |
Change
0.020(0.77%) |
Mkt cap ! $1.801B |
Open | High | Low | Value | Volume |
$2.59 | $2.62 | $2.56 | $2.442M | 940.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6098 | $2.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.62 | 193477 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 12504 | 2.560 |
2 | 2600 | 2.550 |
3 | 12611 | 2.520 |
2 | 5552 | 2.510 |
5 | 21884 | 2.500 |
Price($) | Vol. | No. |
---|---|---|
2.620 | 189630 | 7 |
2.630 | 9631 | 3 |
2.640 | 1611 | 1 |
2.650 | 12633 | 4 |
2.660 | 113092 | 5 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
PNV (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online